Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis

por Pennington, Kelly, Sasieta, Humberto C, Ramos, Guiherme P, Erskine, Courtney L, Van Keulen, Virginia P, Peikert, Tobias, Escalante, Patricio
Publicado 2017

Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 Infection

por Marty, Paige K., Pathakumari, Balaji, Shah, Maleeha, Keulen, Virginia P., Erskine, Courtney L., Block, Matthew S., Arias-Sanchez, Pedro, Escalante, Patricio, Peikert, Tobias
Publicado 2023

Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 Infection

por Pathakumari, Balaji, Marty, Paige K., Shah, Maleeha, Van Keulen, Virginia P., Erskine, Courtney L., Block, Matthew S., Arias-Sanchez, Pedro, Escalante, Patricio, Peikert, Tobias
Publicado 2023

PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction

por Ray, Upasana, Thirusangu, Prabhu, Jin, Ling, Xiao, Yinan, Pathoulas, Christopher L., Staub, Julie, Erskine, Courtney L., Dredge, Keith, Hammond, Edward, Block, Matthew S., Kaufmann, Scott H., Bakkum-Gamez, Jamie N., Shridhar, Viji
Publicado 2023

Risk assessment of latent tuberculosis infection through a multiplexed cytokine biosensor assay and machine learning feature selection

por Robison, Heather M., Chapman, Cole A., Zhou, Haowen, Erskine, Courtney L., Theel, Elitza, Peikert, Tobias, Lindestam Arlehamn, Cecilia S., Sette, Alessandro, Bushell, Colleen, Welge, Michael, Zhu, Ruoqing, Bailey, Ryan C., Escalante, Patricio
Publicado 2021

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

por Norton, Nadine, Fox, Nicholas, McCarl, Christie-Ann, Tenner, Kathleen S., Ballman, Karla, Erskine, Courtney L., Necela, Brian M., Northfelt, Donald, Tan, Winston W., Calfa, Carmen, Pegram, Mark, Colon-Otero, Gerardo, Perez, Edith A., Clynes, Raphael, Knutson, Keith L.
Publicado 2018

Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy

por Marty, Paige K., Van Keulen, Virginia P., Erskine, Courtney L., Shah, Maleeha, Hummel, Amber, Stachowitz, Michael, Fatis, Samantha, Granger, Dane, Block, Matthew S., Duarte-García, Alí, Warrington, Kenneth J., Theel, Elitza S., Zhou, Xian, Zeng, Hu, Specks, Ulrich, Escalante, Patricio, Peikert, Tobias
Publicado 2022

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

por Zamarin, Dmitriy, Walderich, Sven, Holland, Aliya, Zhou, Qin, Iasonos, Alexia E, Torrisi, Jean M, Merghoub, Taha, Chesebrough, Lewis F, Mcdonnell, Autumn S, Gallagher, Jacqueline M, Li, Yanyun, Hollmann, Travis J, Grisham, Rachel N, Erskine, Courtney L, Block, Mathew S, Knutson, Keith L, O’Cearbhaill, Roisin E, Aghajanian, Carol, Konner, Jason A
Publicado 2020

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2

por Mudrick, Haley E., Massey, Shane, McGlinch, Erin B., Parrett, Brian J., Hemsath, Jack R., Barry, Mary E., Rubin, Jeffrey D., Uzendu, Chisom, Hansen, Michael J., Erskine, Courtney L., Van Keulen, Virginia P., Drelich, Aleksandra, Panos, Joseph A., Fida, Madiha, Suh, Gina A., Peikert, Tobias, Block, Matthew S., Tseng, Chien-Te Kent, Olivier, Gloria R., Barry, Michael A.
Publicado 2022

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

por Block, Matthew S., Dietz, Allan B., Gustafson, Michael P., Kalli, Kimberly R., Erskine, Courtney L., Youssef, Bahaaeldin, Vijay, Geraldine V., Allred, Jacob B., Pavelko, Kevin D., Strausbauch, Michael A., Lin, Yi, Grudem, Megan E., Jatoi, Aminah, Klampe, Carolyn M., Wahner-Hendrickson, Andrea E., Weroha, S. John, Glaser, Gretchen E., Kumar, Amanika, Langstraat, Carrie L., Solseth, Mary L., Deeds, Michael C., Knutson, Keith L., Cannon, Martin J.
Publicado 2020